Description
Book SynopsisSince the publication of the pioneering first edition of Chemical Genomics and Proteomics more than seven years ago, the area of chemical genomics has rapidly expanded and diversified to numerous novel methods and subdisciplines, such as chemical glycomics and lipidomics. This second edition has been updated to uniquely reflect this interdisciplinary feature as well as the remarkable developments that have occurred. The new edition also covers innovative applications from cell biology to drug discovery to, more recently, clinical diagnostics and medical practice, which utilize the concepts of chemical genomics.
The text provides an overview of the strategies and methodologies of chemical genomics, focusing on emerging technologies and recent applications in the areas of combination chemical genetics, toxicogenomics, drug chemical genomics and proteomics, and orthogonal chemical genetics. It describes the development and application of novel analytical methods used in l
Trade Review
Praise for the First Edition
"I thoroughly enjoyed this book and have already had to retrieve it from my PhD students who are anxious to read it ...make sure your library has a copy!"
—Journal of Chemical Technology and Biotechnology, Vol. 80, Issue 8, August 2005
"[This book] is the first book dedicated solely to chemical genomics. It presents the most important research and developments in chemical genomics … The plentiful tables and figures are well-designed and effectively support the content. … highly recommended for academic and special libraries with relevant programs, and for research scientists in the field."
—E-Streams
Table of ContentsUtilizing small molecules in chemical genomics: Toward high-throughput approaches. Development and application of novel analytical methods in lipidomics. From chemical genomics to chemical proteomics: The power of microarray technology. Genomic and proteomic biomarkers in the drug R&D process. Quo vadis biomedical sciences in the omics era: Toward computational biology and medicine. Novel chemogenomic approaches to drug design.
